JP2010522550A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010522550A5 JP2010522550A5 JP2010500296A JP2010500296A JP2010522550A5 JP 2010522550 A5 JP2010522550 A5 JP 2010522550A5 JP 2010500296 A JP2010500296 A JP 2010500296A JP 2010500296 A JP2010500296 A JP 2010500296A JP 2010522550 A5 JP2010522550 A5 JP 2010522550A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid according
- cell epitope
- light chain
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 29
- 102000039446 nucleic acids Human genes 0.000 claims 29
- 108020004707 nucleic acids Proteins 0.000 claims 29
- 210000001744 T-lymphocyte Anatomy 0.000 claims 12
- 108060003951 Immunoglobulin Proteins 0.000 claims 5
- 102000018358 immunoglobulin Human genes 0.000 claims 5
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 3
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 3
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000002510 keratinocyte Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0706070.0A GB0706070D0 (en) | 2007-03-28 | 2007-03-28 | Nucleic acids |
| GB0706070.0 | 2007-03-28 | ||
| PCT/EP2008/053761 WO2008116937A2 (en) | 2007-03-28 | 2008-03-28 | Nucleic acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010522550A JP2010522550A (ja) | 2010-07-08 |
| JP2010522550A5 true JP2010522550A5 (enExample) | 2011-02-24 |
| JP5415399B2 JP5415399B2 (ja) | 2014-02-12 |
Family
ID=38050410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010500296A Active JP5415399B2 (ja) | 2007-03-28 | 2008-03-28 | 核酸 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8742088B2 (enExample) |
| EP (2) | EP2134357B1 (enExample) |
| JP (1) | JP5415399B2 (enExample) |
| KR (4) | KR20150013357A (enExample) |
| CN (2) | CN103667304B (enExample) |
| AT (1) | ATE529128T1 (enExample) |
| AU (1) | AU2008231723B2 (enExample) |
| BR (1) | BRPI0808599A2 (enExample) |
| CA (1) | CA2681531C (enExample) |
| DK (2) | DK2193803T3 (enExample) |
| ES (2) | ES2375463T3 (enExample) |
| GB (1) | GB0706070D0 (enExample) |
| PL (1) | PL2134357T3 (enExample) |
| PT (2) | PT2193803E (enExample) |
| WO (1) | WO2008116937A2 (enExample) |
| ZA (1) | ZA200907242B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0706070D0 (en) | 2007-03-28 | 2007-05-09 | Scancell Ltd | Nucleic acids |
| GB201214007D0 (en) | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
| EP3253419A1 (en) | 2015-02-02 | 2017-12-13 | The University of Birmingham | Targeting moiety peptide epitope complexes having a plurality of t-cell epitopes |
| WO2017210149A1 (en) * | 2016-05-31 | 2017-12-07 | Igc Bio, Inc. | Compositions and methods for generating an antibody library |
| US11419928B2 (en) | 2017-10-25 | 2022-08-23 | The Johns Hopkins University | Methods and compositions for treating cancer |
| GB201815041D0 (en) | 2018-09-14 | 2018-10-31 | Scancell Ltd | Epitopes |
| WO2021195089A1 (en) | 2020-03-23 | 2021-09-30 | Sorrento Therapeutics, Inc. | Fc-coronavirus antigen fusion proteins, and nucleic acids, vectors, compositions and methods of use thereof |
| CN111423504B (zh) * | 2020-04-17 | 2021-03-26 | 安徽高安生物医学科技有限公司 | 黑色素瘤特异性抗原肽、肽复合物以及人工抗原呈递细胞 |
| BR112023002195A2 (pt) | 2020-08-26 | 2023-03-14 | Scancell Ltd | Ácido nucleico que codifica um polipeptídeo, vetor, peptídeo, e composição de vacina |
| GB202314361D0 (en) * | 2023-09-19 | 2023-11-01 | Scancell Ltd | Vaccine compositions and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5969109A (en) * | 1990-02-28 | 1999-10-19 | Bona; Constantin | Chimeric antibodies comprising antigen binding sites and B and T cell epitopes |
| ATE204300T1 (de) | 1994-05-13 | 2001-09-15 | Biovation Ltd | Zielzellen-bindende chimäre peptide |
| CA2195642A1 (en) * | 1994-07-27 | 1996-02-08 | Andreas Suhrbier | Polyepitope vaccines |
| US5698679A (en) * | 1994-09-19 | 1997-12-16 | National Jewish Center For Immunology And Respiratory Medicine | Product and process for targeting an immune response |
| AUPO784197A0 (en) * | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
| BR9815289A (pt) * | 1997-11-14 | 2001-12-26 | Euro Celtique Sa | Imunoglobulina modificada, molécula, ácidonucleico isolado, célula contendo o mesmo, animalnão-humano recombinante, composiçãofarmacêutica, composição de vacina, processospara identificar ou medir ou detectar um antìgenode câncer, um antìgeno de um agente de doençainfecciosa, um ligante, e um receptor em umaamostra a ser testada, kits para detecção de umantìgeno de câncer, de um antìgeno de um agentede doença infecciosa, de um receptor celular paraum agente de doença infecciosa, de um ligante, e deum antìgeno de câncer, processos de diagnósticoou de exame para a presença de ou umapredisposição para desenvolvimento de um câncertipificado pela presença aumentada de umantìgeno de câncer, e para a presença de umagente de doença infecciosa, processos detratamento ou de prevenção de um câncertipificado pela presença de um antìgeno de câncer,de uma doença infecciosa tipificada pela presençade um antìgeno de agente de doença infecciosa, ede uma doença causada por um agente de doençainfecciosa que se liga em um receptor celular,processos para modulação de atividade de umprimeiro membro de um par de ligação, processo deprodução de uma imunoglobulina modificada,processo de produção de um ácido nucleicocodificador de imunoglobulina modificada, e, ácidonucleico isolado |
| EP1181320B1 (en) * | 1999-04-27 | 2011-03-09 | Nevagen LLC | Somatic transgene immunization and related methods |
| US7067110B1 (en) * | 1999-07-21 | 2006-06-27 | Emd Lexigen Research Center Corp. | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| GB0102145D0 (en) * | 2001-01-26 | 2001-03-14 | Scancell Ltd | Substances |
| GB0111628D0 (en) | 2001-05-11 | 2001-07-04 | Scancell Ltd | Binding member |
| AU2002331704A1 (en) * | 2001-08-22 | 2003-03-10 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health A | Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods |
| EP1556072B1 (en) * | 2002-09-17 | 2010-05-19 | Antigen Express, Inc. | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
| GB0706070D0 (en) | 2007-03-28 | 2007-05-09 | Scancell Ltd | Nucleic acids |
-
2007
- 2007-03-28 GB GBGB0706070.0A patent/GB0706070D0/en not_active Ceased
-
2008
- 2008-03-28 EP EP08735583.0A patent/EP2134357B1/en active Active
- 2008-03-28 DK DK10152624.2T patent/DK2193803T3/da active
- 2008-03-28 DK DK08735583.0T patent/DK2134357T3/en active
- 2008-03-28 KR KR1020157000952A patent/KR20150013357A/ko not_active Ceased
- 2008-03-28 KR KR1020167020295A patent/KR101729458B1/ko active Active
- 2008-03-28 AT AT10152624T patent/ATE529128T1/de active
- 2008-03-28 KR KR1020177009184A patent/KR20170040387A/ko not_active Ceased
- 2008-03-28 JP JP2010500296A patent/JP5415399B2/ja active Active
- 2008-03-28 CN CN201310487984.6A patent/CN103667304B/zh active Active
- 2008-03-28 CA CA2681531A patent/CA2681531C/en active Active
- 2008-03-28 WO PCT/EP2008/053761 patent/WO2008116937A2/en not_active Ceased
- 2008-03-28 KR KR1020097021806A patent/KR20100015699A/ko not_active Ceased
- 2008-03-28 ES ES10152624T patent/ES2375463T3/es active Active
- 2008-03-28 PT PT10152624T patent/PT2193803E/pt unknown
- 2008-03-28 EP EP10152624A patent/EP2193803B1/en active Active
- 2008-03-28 AU AU2008231723A patent/AU2008231723B2/en active Active
- 2008-03-28 BR BRPI0808599A patent/BRPI0808599A2/pt not_active Application Discontinuation
- 2008-03-28 ES ES08735583.0T patent/ES2638188T3/es active Active
- 2008-03-28 CN CN200880017669.4A patent/CN101678092B/zh active Active
- 2008-03-28 PT PT87355830T patent/PT2134357T/pt unknown
- 2008-03-28 PL PL08735583T patent/PL2134357T3/pl unknown
-
2009
- 2009-09-24 US US12/566,465 patent/US8742088B2/en active Active
- 2009-10-16 ZA ZA2009/07242A patent/ZA200907242B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010522550A5 (enExample) | ||
| JP2012504955A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| JP2022031635A5 (enExample) | ||
| JP2020500538A5 (enExample) | ||
| RU2010120879A (ru) | Антитела против g-белка распираторно-синцитиального вируса (rsv) | |
| JP2018502060A5 (enExample) | ||
| JP2013544492A5 (enExample) | ||
| JP2010516229A5 (enExample) | ||
| JP2011528901A5 (enExample) | ||
| JP2018536393A5 (enExample) | ||
| JP2009511480A5 (enExample) | ||
| JP2018521638A5 (enExample) | ||
| JP2018535650A5 (enExample) | ||
| RU2016119152A (ru) | Стабильные и растворимые антитела, ингибирующие vegf | |
| JP2009225799A5 (enExample) | ||
| JP2011514150A5 (enExample) | ||
| CN105050622A (zh) | 针对呼吸道融合病毒f蛋白质的人类抗体及其使用方法 | |
| JP2013519364A5 (enExample) | ||
| RU2011101969A (ru) | Антитела к человеческому интерлейкину-20 | |
| JP2012518425A5 (enExample) | ||
| JP2009521909A5 (enExample) | ||
| RU2016129113A (ru) | Антитела к pd-1 собак | |
| JP2012512641A5 (enExample) |